HK Stock Market Move | ELIFE HLDGS (00223) resumed trading after more than 1 year and surged 1.61 times in early trading.
Easy Life Holdings (00223) has been suspended since December 2, 2024, and resumed trading this morning with a temporary increase of 1.61 times, before the stock price fell back.
ELIFE HLDGS(00223) has been suspended since December 2, 2024 for over a year. It resumed trading this morning and briefly surged 1.61 times before the stock price fell back. As of the time of writing, it has risen by 70.64% to HK$0.186, with a turnover of HK$2.9448 million.
On the news front, ELIFE HLDGS announced that the company has met the requirements for resumption of trading, including publishing all outstanding financial results and resolving any audit issues; conducting an independent investigation into certain operational subsidiaries for the first half of 2024, evaluating the impact on the company's business operations and financial condition, disclosing the investigation results, and taking appropriate remedial actions; proving compliance with Listing Rule 13.24, which requires sufficient operational business or ownership of tangible or intangible assets of equivalent value; and disclosing all major information to the market.
On November 28, ELIFE HLDGS announced its performance for the six months ending September 30, 2025, showing operating revenue of HK$60.928 million, a 49.0% decrease year-on-year; and a profit attributable to owners of the company of HK$4.365 million, compared to a loss of HK$69.94 million in the same period last year. The announcement stated that this turnaround from loss to profit signifies a major turning point and demonstrates the successful implementation of the management's strategy to stabilize and restore the group's business operations.
Related Articles

YOFC(06869): Shareholder Wuhan Yangtze Communication Industry Group has accumulated a reduction of 1.1 million A shares.

ZGC TEC LEASING (01601) Signs Financing Lease Agreement

FUSEN PHARM(01652): "Compound Potassium Dihydrogen Phosphate Injection" approved for market.
YOFC(06869): Shareholder Wuhan Yangtze Communication Industry Group has accumulated a reduction of 1.1 million A shares.

ZGC TEC LEASING (01601) Signs Financing Lease Agreement

FUSEN PHARM(01652): "Compound Potassium Dihydrogen Phosphate Injection" approved for market.

RECOMMEND

Not Just “Power Shortages,” Delays Will Become The Key Theme For U.S. Data Centers In 2026
26/12/2025

Hang Seng Index Rises 33% This Year, Best Five‑Year Performance; Multiple Institutions Forecast Breakthrough Above 30,000 Next Year
26/12/2025

Gold Rally Has Further To Run, JPMorgan Bullish: Prices Could Reach USD 5,055 By Year‑End 2026
26/12/2025


